Gangotri Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 9.01 M
as on 16-12-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 101.37%
(FY 2022)
- Profit 113.81%
(FY 2022)
- Ebitda 87.71%
(FY 2022)
- Net Worth 39.03%
(FY 2022)
- Total Assets 18.26%
(FY 2022)
About Gangotri Ayurveda
The Corporate was formerly known as Gangotri Ayurveda Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.01 M, as per Ministry of Corporate Affairs (MCA) records.
Ram Bharat, Acharya Balkrishna, Phool Chandra, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233UP2006PTC032322
- Company No.
032322
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gangotri Ayurveda?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Bharat  | Director | 18-Feb-2008 | Current |
| Acharya Balkrishna | Director | 06-Sep-2006 | Current |
| Phool Chandra | Director | 07-Aug-2021 | Current |
| Som Suvedi | Director | 01-Jan-2018 | Current |
Financial Performance of Gangotri Ayurveda.
Gangotri Ayurveda Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 101.37% increase. The company also saw a substantial improvement in profitability, with a 113.81% increase in profit. The company's net worth Soared by an impressive increase of 39.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gangotri Ayurveda?
In 2021, Gangotri Ayurveda had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vedic Broadcasting LimitedActive 18 years 9 monthsAcharya Balkrishna and Phool Chandra are mutual person
Patanjali Natural Biscuits Private LimitedActive 8 years 5 monthsRam Bharat and Phool Chandra are mutual person
Patanjali Food & Herbal Park Private LimitedActive 15 years 11 monthsPhool Chandra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gangotri Ayurveda?
Unlock and access historical data on people associated with Gangotri Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gangotri Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gangotri Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
